Natural Molecular Testing Corporation provides High-Complexity Molecular Clinical Diagnostic Testing for clinicians. They also provide molecular diagnostic testing for pharmacogenetics, women’s health, oncology, infectious disease, and more.
KPMG is a global network of professional firms providing Audit, Tax and Advisory services.
Nixon Peabody LLP is a full-service law firm that helps clients navigate complex challenges in litigation, real estate, corporate law, and finance.
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients.
Ezose Sciences Inc. (pronounced ā-zose) is a glycomics-focused company that leverages its unique, high-throughput glycan analysis technology in two ways:
- as a platform to discover & develop new biomarkers and therapeutic targets
- as a glycoform analytical service to support biologic and biosimilar drug development
UK Trade & Investment’s Life Science Investment Organisation was formed in 2012 with the full support of No10 and the Government’s Life Sciences Advisors to help industry partner with and invest in UK Life Sciences. The team works directly with industry to facilitate R&D collaborations, clinical trials, and commercial operations.
Archimedes Inc. is a healthcare modeling organization. Its core technology - the Archimedes Model - is a clinically realistic, mathematical model of human physiology, diseases, interventions and healthcare systems. The Model is continually validated by comparing the results of simulated trials to the results of real multi-national clinical trials and cohort studies.
The SCGPM was established in 2009 from within the department of Genetics at the Stanford Medical School. The SCGPM now involves more than 60 faculty from 13 departments with diverse research interests spanning basic science to clinical medicine.
Asuragen is a molecular diagnostics company focused on oncology and companion diagnostics with special capabilities in the area of mRNA and miRNA. Based in Austin, Texas, Asuragen has R&D, regulatory, cGMP manufacturing and global commercial capabilities to support a range of molecular diagnostic products providing rapid identification of genetic abnormalities associated with oncology and genetic diseases.
QIAGEN is a leading partner globally in developing and validating companion diagnostics to guide the selection of medicines in treating cancer and other diseases. In July 2012, QIAGEN received FDA approval for the therascreen® KRAS RGQ PCR Kit as a companion diagnostic in patients with metastatic colorectal cancer. The U.S. rollout of therascreen KRAS builds on a strong global leadership position including successes in Japan, where regulators approved the therascreen KRAS and EGFR kits in 2011, and in Europe, where QIAGEN offers 10 CE-marked assays for personalized healthcare applications. QIAGEN has more than 15 projects under way to co-develop and market companion diagnostics with leading pharmaceutical and biotechnology companies.
Rock Health is a non-profit foundation focused on supporting entrepreneurs innovating at the intersection of health care and technology. Rock Health provides funding, mentorship and operational support to high-potential, early stage health startups.
BayBio brings together the collective strength and experience of the world’s most innovative and productive life science cluster, helping companies grow, connect and advocate to solve some of humanity’s most pressing challenges. Online at www.baybio.org.
Through its pioneering sequencing-as-a-service model, Complete Genomics provides the most accurate whole human genomes available today. The ease of use and power of Complete's advanced informatics and analysis systems provide genomic information needed to better understand the prevention, diagnosis, and treatment of diseases. Additional information can be found at http://www.completegenomics.com.
Oracle Health Sciences enables the convergence of the life sciences and healthcare industries with solutions that improve the quality of care, lower costs, and speed time to market. http://www.oracle.com/us/industries/health-sciences/overview/index.html
Fluidigm develops, manufactures and markets microfluidic systems for growth markets in the life science and agricultural biotechnology, or Ag-Bio, industries. Fluidigm’s proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents. These systems are designed to significantly simplify experimental workflow, increase throughput and reduce costs, while providing the excellent data quality demanded by customers. Fluidigm actively markets four microfluidic systems, including nine different commercial chips, to leading academic institutions, diagnostic laboratories, and pharmaceutical, biotechnology and Ag-Bio companies. Fluidigm products are marketed for research purposes only (not for diagnostic use).
For more information, please visit www.fluidigm.com.
The Personalized Medicine Coalition (PMC), representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. For more information about PMC, visit www.PersonalizedMedicineCoalition.org.
SV Bio is a diagnostics company, founded to help medical providers improve patient health and outcomes through an understanding of genomics and molecular information.
Portable Genomics™ develops mobile software for comprehensive visualization and use of personal genomic data for informed healthcare planning and lifestyle adjustments in connection with healthcare professionals.
Microsonic Systems has developed Microprocessor for Life Sciences™ based on its patented and proprietary Bulk Lateral Ultrasonic (BLU)™ technologies. Shearing DNA is a tedious and unreliable process in the workflow for preparing next-generation sequence samples. BLU™ increases the speed, yield, and reliability of DNA shearing.
Janssen Labs is a new life science innovation center created by Janssen Research & Development, LLC (JRD) at its La Jolla-based West Coast Research Center. Janssen Labs provides emerging healthcare companies with an efficient way to discover and develop solutions to the healthcare challenges they face today. This model is intended to give companies the opportunity to invest their capital in research instead of infrastructure and to focus resources on progressing science instead of day-to-day operations. http://www.janssenlabs.com
Accelerated Medical Diagnostics (AMD) is developing the PlatinDx assay, which provides direct measurement of in vivo cellular responses to a microdose (~1/100th the therapeutic dose) of platinum-based chemotherapy agents such as carboplatin and oxaliplatin.
Fish & Richardson is an international law firm exclusively dedicated to intellectual property, litigation, and technology law. Founded in Boston in 1878, the firm has represented some of the greatest inventors of all time, including Alexander Graham Bell, Thomas Edison, and theWright brothers. Recognized as a world leader in intellectual property, the firm has 11 offices in the United States and one in Germany.
As market leader in enterprise application software, SAP helps companies of all sizes and industries run better. From back office to boardroom, warehouse to storefront, desktop to mobile device – SAP empowers people and organizations to work together more efficiently and use business insight more effectively to stay ahead of the competition. SAP HANA is SAP’s breakthrough innovative technology that combines transactional and analytic functions with real-time analytics and acceleration in one platform to significantly improve the processing of enterprise and scientific data. SAP applications and services enable more than 197,000 customers to operate profitably, adapt continuously, and grow sustainably. For more information, visit www.sap.com.
Genection is a genomics company connecting physicians and their patients with the largest genetic test menu available in one place. Genection simplifies the confusing landscape of genetics by providing a marketplace where physicians can order any test they desire for their patient. Physicians view all genetic tests, and have the power to select from multiple labs. Genection is the only company to offer multiple lab choices for Whole Genome Sequencing or Exome Sequencing and genotyping.
Atossa Genetics, Inc., the Breast Health Company™, is located in Seattle, WA. Atossa is a healthcare company focused on the prevention of breast cancer through commercialization of diagnostic tests that detect precursors to breast cancer, and through research, development, and ultimate commercialization of treatments for pre-cancerous lesions.
We at Market Ready Rx understand the importance of a successful commercial launch of a product. As a hands-on partner, we do the heavy lifting while you focus on the other critical parts of the business. Market Ready Rx is dedicated to providing the highest quality programs to leading-edge diagnostic companies in the area of:
- Predictive Companion Diagnostics
- Emerging Molecular Diagnostics
- Immunohistochemistry Systems
More go to: www.marketreadyrx.com
CardioDx is a cardiovascular genomic diagnostics company that is strategically focused on coronary artery disease, cardiac arrhythmia, and heart failure.
Cypher Genomics provides knowledge through simultaneous utilization of information as well as analytical tools necessary to enable genomic interpretation and discovery.
OMI is developing novel biomarkers based on clinical and genomic data and is using information generated from multiple sources to develop new treatments for neuro-immune and other diseases.
Telesofia’s proprietary platform allows health care providers to automatically generate personalized educational videos for their patients, in a way that is friendly, easy to understand and available on any device. The platform is designed to support many applications, such as describing the proper use of their medication, surgical procedure, discharge instructions and more.
Cytobank is a web-based platform that manages, shares, and analyzes flow cytometry data. Now used by academic and industrial researchers around the world to manage, share, and analyze their cytometry data, the Cytobank project started as an approach to manage and analyze the large amounts of mass and flow cytometry data generated in Dr. Garry Nolan’s laboratory at Stanford University.
Brain Resource, Inc. (BRRZY: OTC US, BRC: ASX) translates new findings about the brain into engaging products for consumers, employers and clinicians to improve cognition and brain function. With offices in San Francisco and Australia, and agents in Europe and Israel, the company is underpinned by an international consortium of scientists and clinicians that bring together all aspects about the brain that are usually assessed independently. For more information, follow Brain Resource on Twitter @MyBrainSolution or visit www.brainresource.com.
Horizon Discovery Limited has developed a translational genomics platform and drug discovery toolbox that enables the development of new therapies targeted at the genetic features that drive an individual’s cancer.
Mango Health is making fun and elegant mobile applications that inspire consumers to better manage and improve their health.
The company's first mobile application aims to improve adherence to doctor-prescribed regimens while helping patients proactively improve their health. Mango Health is backed by leading Silicon Valley investors including First Round Capital, Mike Maples (Floodgate), Steve Anderson (Baseline Ventures), Mark Pincus (Zynga) and Keith Rabois (Square).
Omixon helps clinical and diagnostic labs to adopt next generation sequencing by developing precise and validated NGS data analysis software for the benefit of patients.
Using proprietary hardware, software and call center protocols, SentiCare works with patients on complicated medication regimens to ensure the correct medication is taken at the correct time. Proper adherence leads to improved health outcomes, reduced hospitalization, reduced re-admission within 30-90 days after discharge, and significant cost savings for Healthcare and Senior Housing Providers.
Morrison Foerster, imagine lawyers who are as interested in what you do as you are. Who understand the value of your new technology or new product or new transaction. Who are prepared to work with you to create it, protect it and maximize your opportunity to derive value from it. Who'll help you to bring it to fruition, or finance it, or bring it to market, or sell it. And, who are prepared to zealously defend it – in or out of court. Imagine lawyers with imagination. This is MoFo.
Low-cost and integrated DNA sequencing instrument to enable the democratization and decentralization of sequencing - pushing sequencing from the research environment into the clinical setting.
Sofie Biosciences is creating an ever-expanding playing field for molecular imaging, offering a comprehensive range of products from preclinical imaging systems to novel diagnostic PET imaging probes.
Univfy is a privately held company specializing in the development and integration of powerful statistics and computation with an innovative web platform to bring evidence-based, personalized medicine to fertility patients and their healthcare providers. The company was founded in November 2009 by Stanford University professors, Mylene Yao, M.D. and Wing Wong, Ph.D., who had discovered a novel approach to predicting live birth outcomes in in vitro fertilization (IVF).
Recombinant By Deloitte offers life sciences software solutions for translational research. Their standard software packages are toolkits and frameworks for establishing translational research data warehouses and the analytics utilities to maximize use of those data assets.
ASSESSx Technology’s ABATE Qx software is a pain imaging and recording device that collects bio-physiological readings from the skin’s soft-tissue pain sites. The platform offers doctors, nurses and clinicians a way to assess and treat pain cost-effectively and measure soft-tissue inflammation to help a) objectify what patients feel as pain and b) show when the pain is resolved. This pain treatment outcomes data will allow for Evidence Based Medicine/Practices (EBM/EBP).
Bina Technologies is pioneering a new approach to solving the big data challenges in Genomics and Personalized Medicine. Bina's combination of high-performance computing expertise combined with our proprietary statistical algorithms and optimized software provides dramatic improvements in the cost, accuracy, and speed of data analysis.
(Hover over the booth # for more information)